Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

5q- anomaly in lymphoid disorders.

S Kerim1, C Mecucci, A Cuneo

  • 1Center for Human Genetics, University of Leuven, Belgium.

Leukemia
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

The 5q- chromosome anomaly is found in both T and B cell lymphoproliferative disorders. This genetic abnormality, often accompanied by other lymphoid-type changes, shares morphological characteristics with anomalies seen in myeloid disorders.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A window of opportunity: tear cytokine profiles in chronic ocular graft-versus-host disease.

Eye (London, England)·2026
Same author

Seeing the unseen: Use of a modified OSDI questionnaire to accurately detect chronic ocular GVHD in a hematology clinic.

The ocular surface·2022
Same author

[Thoracic insufficiency syndrome].

Acta ortopedica mexicana·2021
Same author

Outcome in patients with diffuse large B-cell lymphoma who relapse after autologous stem cell transplantation and receive active therapy. A retrospective analysis of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation (EBMT).

Bone marrow transplantation·2019
Same author

Selected nitrostyrene compounds demonstrate potent activity in chronic lymphocytic leukaemia cells, including those with poor prognostic markers.

Oncology reports·2019
Same author

Genetic landscape of ultra-stable chronic lymphocytic leukemia patients.

Annals of oncology : official journal of the European Society for Medical Oncology·2018
Same journal

Evolutionary considerations for risk stratification in TP53-variant myeloproliferative neoplasms.

Leukemia·2026
Same journal

Measurable residual disease is not a universally reliable surrogate for progression-free survival in clinical trials of new chronic lymphocytic leukemia therapies.

Leukemia·2026
Same journal

Mantle cell lymphoma artificial intelligence prognostic index using hematoxylin and eosin histology.

Leukemia·2026
Same journal

Redefining light-chain smoldering multiple myeloma: prevalence and progression risk.

Leukemia·2026
Same journal

Decreased TXNRD1 is associated with resistance to tagraxofusp in blastic plasmacytoid dendritic cell neoplasms, as seen in phase II.

Leukemia·2026
Same journal

Retroperitoneal bulk predicts chylothorax in follicular lymphoma-control requires systemic response.

Leukemia·2026
See all related articles

Area of Science:

  • Cytogenetics
  • Hematology
  • Oncology

Background:

  • Lymphoproliferative disorders involve the abnormal proliferation of lymphocytes.
  • Chromosome anomalies are frequently observed in hematologic malignancies.
  • The 5q- anomaly has been previously associated with myeloid disorders.